Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Preferred Stock Liabilities (2018 - 2020)

Outset Medical (OM) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $452.3 million as the latest value for Q2 2020.

  • On a quarterly basis, Preferred Stock Liabilities changed N/A to $452.3 million in Q2 2020 year-over-year; TTM through Jun 2020 was $452.3 million, a N/A change, with the full-year FY2019 number at $409.4 million, up 4.37% from a year prior.
  • Preferred Stock Liabilities was $452.3 million for Q2 2020 at Outset Medical, roughly flat from $452.3 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $452.3 million in Q1 2020 to a low of $409.4 million in Q3 2019.